Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Oncology

Surgery and Local Control: The Path to Clearance

At a Glance

Surgery is currently the only potentially curative treatment for early-stage cholangiocarcinoma. The main goal is an R0 resection, meaning the tumor is completely removed with clear tissue margins. Some patients with perihilar tumors may also be eligible for a highly specialized liver transplant.

Surgery is currently the only treatment with the potential to cure cholangiocarcinoma (CCA). When the cancer is caught in its early stages and has not spread to distant organs, the focus of your medical team shifts toward “local control”—removing the tumor entirely and ensuring no microscopic traces are left behind.

The Gold Standard: R0 Resection

The primary goal of any CCA surgery is to achieve an R0 resection [1][2].

  • What it means: A pathologist examines the edges (margins) of the tissue the surgeon removed. An “R0” result means that no cancer cells were found at the very edge of the sample under a microscope [3].
  • Why it matters: Patients who achieve an R0 margin have significantly better long-term survival outcomes and a lower risk of the cancer returning compared to those with “R1” margins (where microscopic cancer remains) [1][4]. For some types of CCA, surgeons aim for a “buffer zone” of at least 5 mm of healthy tissue to ensure the best possible outcome [5].

The Role of Lymphadenectomy

During surgery, your surgeon will likely perform a lymphadenectomy, which is the removal of nearby lymph nodes [3].

  • Staging Accuracy: Lymph nodes act as the first “landing spots” if cancer begins to spread. Examining them allows your team to accurately stage the disease [6].
  • Prognostic Value: Knowing whether the cancer has reached the lymph nodes is a critical factor in determining your prognosis and deciding if you need “adjuvant” (post-surgery) treatments like chemotherapy to kill any remaining stray cells [4][7].

Individualized Surgical Planning

Modern surgery has moved away from a “one-size-fits-all” approach. Your surgical plan is a unique blueprint based on your specific anatomy [8].

  • Vascular Resection: Because bile ducts sit near major blood vessels (like the portal vein), your surgeon may need to remove and then reconstruct sections of these vessels to achieve a clear R0 margin [3].
  • Adjacent Organs: Depending on the tumor’s location, the surgery may involve removing parts of the liver (hepatectomy) or the head of the pancreas (Whipple procedure) [2].

Liver Transplantation: A Specialized Path

For some patients with perihilar CCA (pCCA) whose tumors are in a location that makes standard surgery impossible, a liver transplant may be considered [9].

  • The Protocol: This typically follows a strict set of rules known as the Mayo Clinic Protocol [10]. It involves a specific course of chemotherapy and radiation to stabilize the tumor, followed by a transplant from a donor [9][11].
  • Eligibility: This option is usually reserved for patients with tumors smaller than 3 cm that have not spread to the lymph nodes [12][13]. For those who meet these strict criteria, 5-year survival rates can be over 50% [14][13].

What to Expect from Surgery

Surgery for CCA is complex and requires a highly skilled surgical team. You may undergo a “frozen section” during the operation—a quick laboratory test where the pathologist checks the margins while you are still in the operating room to help the surgeon decide if more tissue needs to be removed [5][15]. Your care team will use these intraoperative findings to make real-time, individualized decisions to give you the best possible chance for a successful outcome [16].

Common questions in this guide

What does an R0 margin mean in cholangiocarcinoma surgery?
An R0 margin means that a pathologist found no microscopic cancer cells at the very edges of the tissue removed during your operation. Achieving this clear margin offers the best chance for long-term survival and significantly lowers the risk of the cancer returning.
Why do surgeons remove lymph nodes during bile duct cancer surgery?
Lymph nodes are the first places cancer tends to spread once it leaves the primary tumor. Removing and examining these nearby nodes allows your care team to accurately stage your cancer and determine if you need additional treatments like chemotherapy after surgery.
Am I a candidate for a liver transplant for cholangiocarcinoma?
A liver transplant can be a curative option for select patients with perihilar cholangiocarcinoma whose tumors cannot be removed through standard surgery. Patients must typically meet strict eligibility criteria and complete a rigorous protocol involving chemotherapy and radiation prior to transplant.
What is a vascular resection and why might I need one?
Because the bile ducts are located right next to major blood vessels, a tumor may involve these vessels. A vascular resection means the surgeon will remove the affected section of the blood vessel and reconstruct it to ensure the entire tumor is completely cleared.
What happens during a frozen section test during surgery?
A frozen section is a rapid laboratory test performed while you are still in the operating room. A pathologist immediately checks the margins of the removed tissue so the surgeon knows right away if they need to remove more tissue to ensure no cancer cells are left behind.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you believe my cancer is resectable, and what is your plan to achieve an R0 margin?
  2. 2.How many lymph nodes do you intend to remove, and why is that number appropriate for my specific case?
  3. 3.For perihilar cancer: Am I a candidate for the 'Mayo Clinic Protocol' for liver transplantation?
  4. 4.Will you need to perform a vascular resection (removing and repairing blood vessels) during my surgery?
  5. 5.How has my surgical plan been individualized based on my specific tumor location and anatomy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Surgical Therapy of Cholangiocarcinoma.

    Radtke A, Königsrainer A

    Visceral medicine 2016; (32(6)):422-426 doi:10.1159/000452921.

    PMID: 28229077
  2. 2

    [Long-term results of surgical treatment of intrahepatic cholangiocarcinoma].

    Gurmikov BN, Vishnevsky VA, Kovalenko YA, Chzhao AV

    Khirurgiia 2020; 5-11 doi:10.17116/hirurgia20200515.

    PMID: 32500683
  3. 3

    [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].

    Patyutko YI, Polyakov AN, Podluzhnyi DV, et al.

    Khirurgiia 2018; 30-37 doi:10.17116/hirurgia201812130.

    PMID: 30560842
  4. 4

    Survival outcomes of surgical resection in perihilar cholangiocarcinoma in endemic area of O. Viverrini, Northeast Thailand.

    Sarkhampee P, Junrungsee S, Tantraworasin A, et al.

    Asian journal of surgery 2024; (47(7)):2991-2998 doi:10.1016/j.asjsur.2024.03.116.

    PMID: 38519311
  5. 5

    Prognostic Impact of Resection Margin Length in Patients Undergoing Resection for Mid-Common Bile Duct Cancer: A Single-Center Experience.

    Park YH, Seo SH, An MS, et al.

    Digestive surgery 2021; (38(3)):212-221 doi:10.1159/000513563.

    PMID: 33784683
  6. 6

    Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy.

    Hirose Y, Sakata J, Nomura T, et al.

    Surgery 2025; (180()):109099 doi:10.1016/j.surg.2024.109099.

    PMID: 39823650
  7. 7

    Prognostic Impact of Margin Status in Distal Cholangiocarcinoma.

    Nakagohri T, Takahashi S, Ei S, et al.

    World journal of surgery 2023; (47(4)):1034-1041 doi:10.1007/s00268-023-06889-7.

    PMID: 36735046
  8. 8

    Selective lymph node dissection in intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma may not impair oncological outcomes: a single-center retrospective cohort study.

    Lu WH, Liao TK, Su CM, et al.

    World journal of surgical oncology 2025; (23(1)):387 doi:10.1186/s12957-025-04034-3.

    PMID: 41121221
  9. 9

    Liver transplantation in the management of perihilar cholangiocarcinoma.

    Gulamhusein AF, Sanchez W

    Hepatic oncology 2015; (2(4)):409-421 doi:10.2217/hep.15.30.

    PMID: 30191020
  10. 10

    Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma.

    Hewitt DB, Brown ZJ, Pawlik TM

    Cancers 2022; (14(9)) doi:10.3390/cancers14092208.

    PMID: 35565335
  11. 11

    Liver Transplantation for Peri-hilar Cholangiocarcinoma.

    Tan EK, Taner T, Heimbach JK, et al.

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2020; (24(11)):2679-2685 doi:10.1007/s11605-020-04721-4.

    PMID: 32671802
  12. 12

    Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.

    Ethun CG, Lopez-Aguiar AG, Anderson DJ, et al.

    Annals of surgery 2018; (267(5)):797-805 doi:10.1097/SLA.0000000000002574.

    PMID: 29064885
  13. 13

    Single-center experience of liver transplantation for perihilar cholangiocarcinoma.

    Ahmed O, Vachharajani N, Chang SH, et al.

    HPB : the official journal of the International Hepato Pancreato Biliary Association 2022; (24(4)):461-469 doi:10.1016/j.hpb.2021.08.940.

    PMID: 34465528
  14. 14

    Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.

    Vugts JJA, Gaspersz MP, Roos E, et al.

    Annals of surgical oncology 2021; (28(3)):1483-1492 doi:10.1245/s10434-020-09001-8.

    PMID: 32901308
  15. 15

    Current status of liver transplantation for cholangiocarcinoma.

    Twohig P, Peeraphatdit TB, Mukherjee S

    World journal of gastrointestinal surgery 2022; (14(1)):1-11 doi:10.4240/wjgs.v14.i1.1.

    PMID: 35126858
  16. 16

    Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

    Banales JM, Rodrigues PM, Affò S, et al.

    Nature reviews. Gastroenterology & hepatology 2026; (23(1)):65-96 doi:10.1038/s41575-025-01153-w.

    PMID: 41372578

This page provides educational information about surgical options and pathology terminology for cholangiocarcinoma. It does not replace professional medical advice. Always discuss your specific surgical plan and eligibility with an experienced hepatobiliary surgeon.

Get notified when new evidence is published on Cholangiocarcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.